SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-026288
Filing Date
2018-11-01
Accepted
2018-11-01 17:01:25
Documents
68
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cbio-10q_20180930.htm 10-Q 1843946
2 EX-31.1 cbio-ex311_8.htm EX-31.1 13594
3 EX-31.2 cbio-ex312_6.htm EX-31.2 13681
4 EX-32.1 cbio-ex321_9.htm EX-32.1 9779
5 EX-32.2 cbio-ex322_7.htm EX-32.2 9583
  Complete submission text file 0001564590-18-026288.txt   6077986

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cbio-20180930.xml EX-101.INS 1268434
7 XBRL TAXONOMY EXTENSION SCHEMA cbio-20180930.xsd EX-101.SCH 45621
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbio-20180930_cal.xml EX-101.CAL 38601
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbio-20180930_def.xml EX-101.DEF 136107
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20180930_lab.xml EX-101.LAB 332735
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20180930_pre.xml EX-101.PRE 267249
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 6507450655
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51173 | Film No.: 181154638
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1